Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Nuklearmedizin. Nuclear Medicine|April 4, 2018
[Evaluation of intra- and interobserver agreement of Technetium-99m-sestamibi imaging in cold thyroid nodules]Justus Baumgarten, Christian Happel, Hanns Ackermann, et al.
Laryngo- Rhino- Otologie|June 23, 2022
[Radiofrequency ablation of benign thyroid nodules]Frank Grünwald, Justus Baumgarten, Christian Happel, et al.
Clinical Case Reports|May 8, 2023
Thyroid papillary cancer elements arising from struma ovarii with benign peritoneal strumosis: Utility of iodine-123 imaging in diagnostics and treatment planningDaniel Groener, Justus Baumgarten, Christian Happel, et al.
Current Oncology (Toronto, Ont.)|June 23, 2022
Retrospective Analysis of the Development of Human Thyroglobulin during Pregnancy in Patients with Treated Non-Recurrent Differentiated Thyroid CancerJustus Baumgarten, Christian Happel, Daniel Groener, et al.
Nuklearmedizin. Nuclear Medicine|February 16, 2022
[Anticipating Criteria for Discharge after Lu-177-PSMA Treatment - Discussion of Several Scenarios]Wolfgang Tilman Kranert, Benjamin Bockisch, Jennifer Wichert, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 26, 2023
Extended therapy with [177Lu]Lu-PSMA-617 in responding patients with high-volume metastatic castration-resistant prostate cancerNicolai Mader, Christina Nguyen Ngoc, Bilge Kirkgöze, et al.
Cancers|August 27, 2021
Salvage Radioligand Therapy with Repeated Cycles of 177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer with Diffuse Bone Marrow InvolvementDaniel Groener, Justus Baumgarten, Sebastian Haefele, et al.
Cancers|January 21, 2023
Baseline [68Ga]Ga-PSMA-11 PET/CT before [177Lu]Lu-PSMA-617 Radioligand Therapy: Value of PSMA-Uptake Thresholds in Predicting Targetable LesionsDaniel Groener, Sina Schneider, Justus Baumgarten, et al.
Cancers|February 15, 2022
Safety and Efficacy of 177Lutetium-PSMA-617 Radioligand Therapy Shortly after Failing 223Radium-DichlorideJustus Baumgarten, Daniel Groener, Christina Nguyen Ngoc, et al.
Cancers|August 12, 2023
Impact of [177Lu]Lu-PSMA-617 Radioligand Therapy on Reference Organ Uptake Assessed by [68Ga]Ga-PSMA-11-PET/CTDaniel Groener, Jennifer Wichert, Magdalena Adams, et al.
Pageof 2